US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines
University of Southern California · University of Hawaii Cancer Center · +12 more institutions
Abstract
This study sought to determine the prevaccine type-specific prevalence of human papillomavirus (HPV)-associated cancers in the United States to evaluate the potential impact of the HPV types in the current and newly approved 9-valent HPV vaccines.
The Centers for Disease Control and Prevention partnered with seven US population-based cancer registries to obtain archival tissue for cancers diagnosed from 1993 to 2005. HPV testing was performed on 2670 case patients that were fairly representative of all participating cancer registry cases by age and sex. Demographic and clinical data were evaluated by anatomic site and HPV status. Current US cancer registry data and the detection of HPV types were used to estimate the number of cancers potentially preventable through vaccination.
Citation impact
- FWCI
- 39.07
- Percentile
- 100%
- References
- 46
Authors
17- MSMona Saraiya
University of Southern California, University of Hawaii Cancer Center, Centers for Disease Control and Prevention, National Cancer Institute, Louisiana State University Health Sciences Center New Orleans, Florida Department of Health, University of Florida, National Center for Emerging and Zoonotic Infectious Diseases, Battelle, National Center for Chronic Disease Prevention and Health Promotion, University of Kentucky, University of Hawaii System, Michigan Department of Health and Human Services, University of Iowa
- ERElizabeth R. Unger
Florida Department of Health, University of Kentucky, Battelle, National Center for Chronic Disease Prevention and Health Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, University of Florida, National Cancer Institute, University of Iowa, Michigan Department of Health and Human Services, Louisiana State University Health Sciences Center New Orleans, University of Hawaii Cancer Center, University of Southern California, University of Hawaii System
- TTTrevor Thompson
University of Kentucky, Louisiana State University Health Sciences Center New Orleans, University of Hawaii System, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Michigan Department of Health and Human Services, University of Iowa, National Cancer Institute, Battelle, University of Hawaii Cancer Center, Florida Department of Health, National Center for Emerging and Zoonotic Infectious Diseases, University of Southern California, University of Florida
- CFCharles F. Lynch
University of Hawaii Cancer Center, University of Florida, University of Southern California, Louisiana State University Health Sciences Center New Orleans, National Cancer Institute, Michigan Department of Health and Human Services, University of Kentucky, Battelle, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, National Center for Chronic Disease Prevention and Health Promotion, Florida Department of Health, University of Iowa, University of Hawaii System
- BYBrenda Y. Hernandez
University of Kentucky, Battelle, Michigan Department of Health and Human Services, Louisiana State University Health Sciences Center New Orleans, University of Iowa, University of Hawaii System, Florida Department of Health, University of Southern California, University of Hawaii Cancer Center, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, University of Florida, National Cancer Institute
Topics & keywords
- Medicine
- HPV vaccines
- Cancer
- Cervical cancer
- Population
- Oncology
- Cancer registry
- Vulvar cancer
- Good health and well-being